ETS1 p.Pro194Ser
c.580C>T · VCV3846398
Computational evidence
| Protein change | ||
| AlphaMissense | 0.074 | likely benign |
|---|---|---|
| REVEL | 0.039 | moderately benign-leaning |
| SaProt | LLR -5.90 | tolerated |
| ⇒ AlphaMissense, REVEL and SaProt all call this tolerated. | ||
| Splicing | ||
| SpliceAI | <0.2 | no splice effect predicted · four deltas, not one · how we know |
| Constraint at this position | ||
| Conservation | phyloP 8.7 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 0.62 | unconstrained · MANE · 5,627 bp · p 3.8e-08 · regional, not allelic |
| Overall | ||
| CADD | 22.6 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P150S vs ClinVar P194S) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,432 |
| European (non-Finnish)grpmax | 0.00017% | 588,998 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- ETS1
- Protein
- p.Pro194Ser
- Coding
- c.580C>T
- MANE Select
- NM_001143820
- Type
- single nucleotide variant
- Location
- chr11:128486102 (GRCh38)
- Gene constraint
- LOEUF 0.393 · pLI 1.00 (gnomAD)
- Structure
- AlphaFold pLDDT 65.95 · 21 PDB
- Residue 150 UniProt numbering
- the 'activation domain; required for transcription activation' region
Similar variants
- ETS1 c.*1736A>G Benign ★★ same type
- ETS1 p.Ala151Thr Likely benign ★★ same type
- ETS1 p.Arg307= Benign ★★ same type
- ETS1 p.Pro12= Benign ★★ same type
- ETS1 p.Ser200= Benign ★★ same type
- ETS1 p.Arg35Ter Likely pathogenic ★ same type
- ETS1 p.Ala337Ser Uncertain significance ★ ⚠ same type
- ETS1 p.Ala338Val Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ets1-p-pro194ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown